# Auryxia

NDC: 59922-631
Generic name: ferric citrate
Labeler / Manufacturer: Akebia Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20140917

FDA application: NDA205874

## Active ingredients

- TETRAFERRIC TRICITRATE DECAHYDRATE: 210 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59922-631"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59922-631
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aadd18e0-3752-11e4-8510-0800200c9a66